Supports a wide range of users from novices to experts, serving a wide variety of needs

Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has launched worldwide sales of STAvesta, a thermal analyzer that simultaneously measures a sample’s weight and change in calorific value during heating. STAvesta responds to needs in a wide array of fields where thermal analysis is required. It is expected to find use in a wide variety of material-analysis applications for the development of advanced features and complex materials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250708207135/en/

STAvesta

FlatBlank, a Revolutionary Auto-adjustment Feature, Dramatically Reduces Workload
In conventional thermal analysis, baseline adjustment must be performed by hand before measurement can begin. This process can be time-consuming and frustrating, particularly for novice users. Rigaku’s newly developed FlatBlank, a baseline auto-adjustment feature, automates this process, dramatically reducing waiting time associated with the process. Measurement can begin as soon as preparations are ready, enabling smooth setup after sample insertion and improving work efficiency overall. The benefits are particularly pronounced in workplaces conducting R&D handling multiple samples.

Key Features of STAvesta

Broad support for a wide range of users
STAvesta easily switches among seven types of electric furnace¹ according to purpose and measurement conditions. A real-time imaging feature enables samples to be observed during measurement, contributing to improved speed and accuracy in R&D.
1. Six types of electric furnace in some sales countries.
Vestaeye, a new, world-first feature, provides self-diagnosis for constant monitoring of device status.
Before and during measurement, the device monitors itself constantly for signs of abnormality. Users can confirm at a glance whether the device is functioning correctly before starting measurement, so waste of precious samples is eliminated.
Next-generation thermal analysis features for outstanding temperature-control performance
In thermal analysis, when a temperature is set for a sample, the sample may fail to heat up to that setting or may heat up above that setting, precluding accurate measurement. Rigaku’s new temperature control feature dramatically reduces this problem of incorrect temperature. Samples are heated to and held at the required temperature in strict accordance with the preset temperature program. As a result, researchers can easily obtain the intended reactions and obtain stable measurement.
Rapid processing of up to 52 samples in a compact device
STAvesta’s automatic sample changer dramatically increases the number of samples that can be handled from 28 in the previous model to 52. With 2.3 times the transport speed of the previous model and support for up to 1,000 continuous measurements, STAvesta achieves superb measurement efficiency. The tray section supports gas flow, making it ideal for measurement of powders that are prone to moisture absorption. STAvesta is designed so that attachment of the automatic sample changer does not increase its footprint, assuring industry-leading space-saving performance.

Kiyoshi Ogata, Senior Executive Vice President and General Manager of the Product Division, offered the following comment:
Our aim in developing STAvesta was to create a new standard in thermal analyzer. The device incorporates not only improved operability but also support features such as self-diagnostic features for failure detection, so users can use it with confidence. Measurement features are also dramatically strengthened. The device is packed with advanced technologies, such as a structure that rapidly reduces oxygen concentration to support metallic and inorganic samples that are prone to oxidation. In short, this revolutionary thermal analyzer achieves both efficiency and reliability in the R&D workspace.

In launching this product, Rigaku is entering a new market in earnest, drawing on the trust and track record it has accumulated over many years. Leveraging its solid operating base in Japan, Rigaku aims to establish a firm and strong presence in global markets.

Learn more about STAvesta
URL: https://rigaku.com/products/thermal-analysis/sta/stavesta?setLang=english

About the Rigaku Group
Since its establishment in 1951, the engineering professionals of the Rigaku group have been dedicated to benefiting society with leading-edge technologies, notably including its core fields of X-ray and thermal analysis. With a market presence in over 90 countries and some 2,000 employees from 9 global operations, Rigaku is a solution partner in industry and research analysis institutes. Our overseas sales ratio has reached approximately 70% while sustaining an exceptionally high market share in Japan. Together with our customers, we continue to develop and grow. As applications expand from semiconductors, electronic materials, batteries, environment, resources, energy, life science to other high-tech fields, Rigaku realizes innovations “To Improve Our World by Powering New Perspectives.”
For details, please visit rigaku-holdings.com/english

View source version on businesswire.com: https://www.businesswire.com/news/home/20250708207135/en/

Press Contact:
Sawa Himeno
Head of Communications Dept., Rigaku Holdings Corporation
prad@rigaku.co.jp
Tel: +81 90 6331 9843

Logo

Images

Tags

More Like This

Rigaku Collaborates on X-ray Analysis of Fusuma-e by Maruyama Okyo

Rigaku Conducts Elemental Analysis of a Sample Obtained by NASA of the Asteroid Bennu

Rigaku Expands Production Facilities for the Semiconductor Market

Rigaku Launches Fourth Generation Handheld 1064 nm Raman Analyzer for Chemical Threat Analysis at IAFC HAZMAT 2025

Rigaku Announces XSPA-200 ER Detector for X-ray Diffraction System

Rigaku: Novel Electron Density Topography Technology to Reveal Biological Macromolecules’ Properties

Rigaku Completes New Building at Yamanashi Plant

Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development